Kidoguchi et al. [44] showed the natriuretic effect of Azilsartan by inhibiting the WNK4-SPAK-NCC pathway through sympathetic inhibitory activity in a model of adenine-induced chronic renal failure. This evidence concerns the gene SLC12A3 and chronic kidney disease.